Quantinno Capital Management »

Immunome shares owned by Quantinno Capital Management

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Quantinno Capital Management from 13F filings

Historical chart of Quantinno Capital Management investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Quantinno Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Quantinno Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $222k 10k 21.87

More positions owned by Quantinno Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Tesla Motors (TSLA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)

View all positions for Quantinno Capital Management

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Vanguard Group
Redmile Group
PRIMECAP Management Company
Vanguard Capital Management
State Street Corporation
Driehaus Capital Management
Enavate Sciences GP
Morgan Stanley
Geode Capital Management
Leucadia National Corporation
Sofinnova Ventures
Woodline Partners

View all funds holding Immunome